Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
Intestinal Research|December 5, 2025
Comparison between endoscopic resection and transanal surgery for treatment of rectal tumors: a systematic review and meta‑analysisChan Hyuk Park, Byung Wook Jung, Yoon Suk Jung
United European Gastroenterology Journal|August 9, 2023
Impact of proton pump inhibitors on the risk of small bowel or colorectal bleeding: A systematic review and meta-analysisYoon Suk Jung, Jung Ho Park, Chan Hyuk Park
Clinical and Translational Gastroenterology|August 10, 2023
Comparative Efficacy of Tegoprazan vs Esomeprazole/Sodium Bicarbonate for the Treatment of Helicobacter pylori InfectionChan Hyuk Park, Jung Ho Park, Yoon Suk Jung
Journal of Gastroenterology and Hepatology|January 24, 2019
Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseasesMinkyung Han, Yoon Suk Jung, Jae Hee Cheon, et al.
Yonsei Medical Journal|May 12, 2020
Similar Clinical Outcomes of Early and Late Anti-TNF Initiation for Ulcerative Colitis: A Nationwide Population-Based StudyMinkyung Han, Yoon Suk Jung, Jae Hee Cheon, et al.
The Korean Journal of Internal Medicine|April 21, 2020
Impact of early anti-TNF use on clinical outcomes in Crohn's disease: a nationwide population-based studyYoon Suk Jung, Minkyung Han, Sohee Park, et al.
Journal of Gastroenterology and Hepatology|July 1, 2026
Preventive Effect of Helicobacter pylori Treatment on Colorectal Cancer Incidence and MortalityYoon Suk Jung, Somin Jeon, Boyoung Park, et al.
Digestive Diseases and Sciences|November 3, 2019
Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based StudyYoon Suk Jung, Minkyung Han, Sohee Park, et al.
Gut and Liver|August 26, 2020
Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn's DiseaseYoon Suk Jung, Minkyung Han, Sohee Park, et al.
Yonsei Medical Journal|December 31, 2019
Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based StudyMinkyung Han, Yoon Suk Jung, Jae Hee Cheon, et al.
Pageof 17